Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype-Reference-Cited by-同舟云学术

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Published:2018-03 Issue:2 Volume:12 Page:83-86
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Adams Paul, ,Altes Albert,Brissot Pierre,Butzeck Barbara,Cabantchik Ioav,Cançado Rodolfo,Distante Sonia,Evans Patricia,Evans Robert,Ganz Tomas,Girelli Domenico,Hultcrantz Rolf,McLaren Gordon,Marris Ben,Milman Nils,Nemeth Elizabeta,Nielsen Peter,Pineau Brigitte,Piperno Alberto,Porto Graça,Prince Dianne,Ryan John,Sanchez Mayka,Santos Paulo,Swinkels Dorine,Teixeira Emerência,Toska Ketil,Vanclooster Annick,White Desley

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/article/10.1007/s12072-018-9855-0/fulltext.html

Reference9 articles.

1. Vanclooster A, et al. The quality of hereditary haemochromatosis guidelines: a comparative analysis. Clin Res Hepatol Gastroenterol 2015;39(2):205–214.

2. European Association For The Study Of The Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010;53(1):3–22.

3. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54(1):328–343.

4. Bardou-Jacquet E, et al. Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis. J Hepatol 2015;62(3):682–689.

5. Ong SY, et al. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial. Lancet Haematol 2017;4(12):607–614.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Manifestations of Hemochromatosis;Cardiology in Review;2024-08-15

2. Hemochromatosis—How Not to Overlook and Properly Manage “Iron People”—A Review;Journal of Clinical Medicine;2024-06-23

3. Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation;Frontiers in Medicine;2024-03-19

4. Hemocromatosis;Medicine - Programa de Formación Médica Continuada Acreditado;2024-03

5. Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study;Liver International;2024-01-23